cgt6297
HER2-low Breast Cancer
Cogent Biosciences, Inc.Phase 1
—
Rating in progress
cgt6297 in HER2-low Breast Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active